| scholarly article | Q13442814 |
| P50 | author | Pieter Vermeersch | Q74614218 |
| João Tiago Guimarães | Q40104621 | ||
| Kjell Grankvist | Q40580136 | ||
| Giuseppe Lippi | Q45791880 | ||
| Mercedes Ibarz | Q60655958 | ||
| P2093 | author name string | Mads Nybo | |
| Gunn B B Kristensen | |||
| Ana-Maria Simundic | |||
| Alexander von Meyer | |||
| Janne Cadamuro | |||
| Michael Cornes | |||
| Barbara de la Salle | |||
| Edmee van Dongen | |||
| Lases5 | |||
| P2860 | cites work | Errors in a stat laboratory: types and frequencies 10 years later | Q80381672 |
| Hemoglobin, bilirubin, and lipid interference on Roche Cobas 6000 assays | Q82039360 | ||
| Lipaemic samples: effective process for lipid reduction using high speed centrifugation compared with ultracentrifugation | Q82805204 | ||
| Evaluation of the interference of hemoglobin, bilirubin, and lipids on Roche Cobas 6000 assays | Q84111640 | ||
| Comparison of visual vs. automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye? | Q84584603 | ||
| Practices for Identifying and Rejecting Hemolyzed Specimens in Europe | Q87787779 | ||
| Call for more transparency in manufacturers declarations on serum indices: On behalf of the Working Group for Preanalytical Phase (WG-PRE), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) | Q88264711 | ||
| Medical error—the third leading cause of death in the US | Q28005455 | ||
| Practical recommendations for statistical analysis and data presentation in Biochemia Medica journal. | Q34182893 | ||
| 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati | Q34491521 | ||
| The use of S-Monovette is effective to reduce the burden of hemolysis in a large urban emergency department | Q35460079 | ||
| Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories | Q37207286 | ||
| Lipemia: causes, interference mechanisms, detection and management | Q37607322 | ||
| Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories | Q37923504 | ||
| Hemolysis rates in blood samples: differences between blood collected by clinicians and nurses and the effect of phlebotomy training | Q38801799 | ||
| Reporting altered test results in hemolyzed samples: is the cure worse than the disease? | Q38957655 | ||
| A pragmatic approach to sample acceptance and rejection | Q38978232 | ||
| The relationship between vacuum and hemolysis during catheter blood collection: a retrospective analysis of six large cohorts | Q39010043 | ||
| Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group "Laboratory Errors and Patient Safety" project. | Q39092127 | ||
| Error identification in a high-volume clinical chemistry laboratory: Five-year experience | Q41339992 | ||
| Pre-analytical errors management in the clinical laboratory: a five-year study | Q42722313 | ||
| Effects of haemolysis, icterus and lipaemia on coagulation tests as performed on Stago STA-Compact-Max analyser | Q45855275 | ||
| Haemolysis index--an estimate of preanalytical quality in primary health care | Q46497019 | ||
| Low vacuum and discard tubes reduce hemolysis in samples drawn from intravenous catheters | Q46581989 | ||
| Interference of blood cell lysis on routine coagulation testing | Q46924579 | ||
| Influence of hemolysis on routine clinical chemistry testing | Q46977318 | ||
| To report or not to report: a proposal on how to deal with altered test results in hemolytic samples | Q47342914 | ||
| Visual assessment of sample quality: quo usque tandem? | Q48151877 | ||
| Practical recommendations for managing hemolyzed samples in clinical chemistry testing | Q48159641 | ||
| Correction and reporting of potassium results in haemolysed samples. | Q50769227 | ||
| Harmonization of automated hemolysis index assessment and use: Is it possible? | Q53136253 | ||
| Internal quality assurance of HIL indices on Roche Cobas c702 | Q62793688 | ||
| European survey on preanalytical sample handling - Part 1: How do European laboratories monitor the preanalytical phase? On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Ph | Q64975427 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 020705 | |
| P577 | publication date | 2019-06-01 | |
| P1433 | published in | Biochemia Medica | Q15746691 |
| P1476 | title | European survey on preanalytical sample handling - Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) | |
| P478 | volume | 29 |
| Q64975427 | European survey on preanalytical sample handling - Part 1: How do European laboratories monitor the preanalytical phase? On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Ph |
| Q91634783 | Rejection of hemolyzed samples can jeopardize patient safety |
Search more.